Detalhe da pesquisa
1.
A genetic variant of CXCR4 predicts pegylated interferon-alpha treatment response in HBeAg-positive chronic hepatitis B patients.
J Clin Microbiol
; 62(2): e0139623, 2024 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38259071
2.
CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer.
Drug Resist Updat
; 67: 100912, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623445
3.
Application of European-specific polygenic risk scores for predicting prostate cancer risk in different ancestry populations.
Prostate
; 83(1): 30-38, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996327
4.
Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
J Transl Med
; 21(1): 446, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415201
5.
Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Clin Genet
; 103(6): 636-643, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36840471
6.
Calibration of polygenic risk scores is required prior to clinical implementation: results of three common cancers in UKB.
J Med Genet
; 59(3): 243-247, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443076
7.
The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.
Br J Cancer
; 126(5): 791-796, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799695
8.
Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
Int J Cancer
; 148(7): 1658-1664, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300603
9.
Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer.
Prostate
; 81(13): 971-982, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254325
10.
Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients.
Prostate
; 81(10): 703-709, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956350
11.
Assessing the clinical utility of genetic risk scores for targeted cancer screening.
J Transl Med
; 19(1): 41, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482857
12.
Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
J Cell Biochem
; 121(3): 2559-2570, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646670
13.
Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression.
Prostate
; 80(14): 1253-1262, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32803894
14.
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
Br J Cancer
; 123(9): 1356-1359, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32830201
15.
Family history is significantly associated with prostate cancer and its early onset in Chinese population.
Prostate
; 79(15): 1762-1766, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31497879
16.
Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
Prostate
; 78(16): 1222-1228, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043417
17.
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
Prostate
; 78(8): 607-615, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520813
18.
Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis.
BJU Int
; 122(5): 808-813, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29727914
19.
A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
Prostate
; 77(11): 1213-1220, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28656603
20.
Reclassification of prostate cancer risk using sequentially identified SNPs: Results from the REDUCE trial.
Prostate
; 77(11): 1179-1186, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28670847